Document is current

Article History

Received: 9 July 2024

Accepted: 26 March 2025

First Online: 19 May 2025

Declarations

:

: The study was approved by the Ethics Committee of the Medical Faculty of LMU Munich (Project Number 21-1091) with a letter of confirmation dating from 09.12.2021. The latest version of the protocol (No. 4; dating from 06.09.2022) serving as the basis of the publication received ethics approval on 26.09.2022.Important protocol modifications (e.g., changes to eligibility criteria, outcomes, analyses) to relevant parties (e.g., investigators, institutional review board, trial participants, trial registry) were communicated by the study coordinating center (LMU). Written informed consent was obtained from all subjects before entering the study.Study patients or their legal representatives were informed about the study by the previously treating NER clinic by post and were asked to provide their informed written consent. For patients who could not be contacted after two attempts, endpoints of the retrospective study part were collected fully anonymized based on the medical records of the discharging NER facility and status of survival was collected by Residents’ Registration Office query. For the follow-up interview, written informed consent had to be provided by the patients (or by their legal representative if the patient was not able to consent) before data collection was performed.

: Not applicable.

: The authors declare that they have no competing interests.